期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 1, 页码 84-91出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI62838
关键词
-
资金
- Telethon [GGP11141]
- CARIPLO [pr.2008.2275]
- Fondation Leducq [08CVD01]
- Fondazione Veronesi Award on inherited arrhythmogenic diseases
- Ministero Salute [GR2010_2315996]
The discovery of the genetic basis of inherited arrhythmias has paved the way for an improved understanding of arrhythmogenesis in a wide spectrum of life-threatening conditions. In vitro expression of mutations and transgenic animal models have been instrumental in enhancing this understanding, but the applicability of results to the human heart remains unknown. The ability to differentiate induced pluripotent stem cells (iPSs) into cardiomyocytes enables the potential to generate patient-specific myocytes, which could be used to recapitulate the features of inherited arrhythmias in the context of the patient's genetic background. Few studies have been reported on iPS-derived myocytes obtained from patients with heritable arrhythmias, but they have demonstrated the applicability of this innovative approach to the study of inherited arrhythmias. Here we review the results achieved by iPS investigations in arrhythmogenic syndromes and discuss the existing challenges to be addressed before the use of iPS-derived myocytes can become a part of personalized management of inherited arrhythmias.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据